About UsCROI 2013: Growing Number of HIV+ New Yorkers Achieve Viral Load Suppression [VIDEO]
- Details
- Category: HIV Treatment
- Published on Wednesday, 10 April 2013 00:00
- Written by Gregory Fowler
Expanded testing, earlier treatment, and better engagement in care has led to more people with HIV in New York City achieving and maintaining undetectable viral load, according to study findings presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) last month in Atlanta.
CROI 2013: Antiretroviral Therapy Intensification plus IL-7 Does Not Reduce HIV Reservoir
- Details
- Category: Search for a Cure
- Published on Wednesday, 10 April 2013 00:00
- Written by Liz Highleyman
An intensive antiretroviral regimen containing raltegravir (Isentress) and maraviroc (Selzentry) plus the immune-modulator interleukin 7 (IL-7) was unable to decrease the amount of residual HIV in resting CD4 T-cells, investigators with the ERAMUNE-01 trial reported at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.
CROI 2013: Women's PrEP Trial Does Not Show HIV Risk Reduction [VIDEO]
- Details
- Category: HIV Prevention
- Published on Sunday, 24 March 2013 00:00
- Written by Gregory Fowler
Long-awaited results from the VOICE trial of post-exposure prophylaxis (PrEP) for women in Africa, presented at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta, was not able to show that daily oral tenofovir plus emtricitabine (the drugs in Truvada) could lower the risk of HIV acquisition.
French Cohort of HIV+ People Treated Early Appear to Control Virus
- Details
- Category: Search for a Cure
- Published on Monday, 25 March 2013 00:00
- Written by Liz Highleyman
A group of French HIV patients who started antiretroviral therapy (ART) during the earliest stage of infection appear to be controlling the virus despite prolonged treatment interruption, according to a recent report in PLoS Pathogens. While the findings do not represent a cure, they may offer insight to help certain people with HIV achieve a "functional cure," or periods off treatment without disease progression.
CROI 2013: Maraviroc Does Not Prevent Immune Reconstitution Syndrome [VIDEO]
- Details
- Category: HIV Prevention
- Published on Sunday, 24 March 2013 00:00
- Written by Gregory Fowler
The CCR5 co-receptor blocker maraviroc (Selzentry) did not reduce the risk of developing immune reconstitution inflammatory syndrome (IRIS) after starting antiretroviral therapy (ART), according to study findings presented at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.
CROI 2013: Researchers Look at Neurological Complications among People with HIV
- Details
- Category: HIV-Related Conditions
- Published on Monday, 25 March 2013 00:00
- Written by Matt Sharp
Data from a small, yet well-designed trial to evaluate whether particular antiretroviral therapy (ART) regimens penetrate the central nervous system (CNS) and enhance neurocognitive performance were among several interesting findings regarding neurological complications among people with HIV presented at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) this month in Atlanta. Another study looked at similarities between Alzheimer's disease and neurocognitive impairment in people with HIV.
CROI 2013: Statins for People with HIV -- How Sweet Is It?
- Details
- Category: HIV-Related Conditions
- Published on Thursday, 21 March 2013 00:00
- Written by Matt Sharp
Statins may help reduce co-morbid conditions such as cardiovascular disease and lower mortality for some people with HIV, but with a possible trade-off of higher diabetes risk, according to a series of studies presented and discussed at 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) this month in Atlanta.
CROI 2013: Transmitted Antiretroviral Drug Resistance Holds Steady at 16% [VIDEO]
- Details
- Category: HIV Treatment
- Published on Monday, 25 March 2013 00:00
- Written by Gregory Fowler
Approximately 1 in 6 analyzed HIV sequences showed evidence of antiretroviral drug resistance, with NNRTIs being particularly vulnerable, according to a CDC analysis presented at the recent 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.
CROI 2013: Functional Cure of HIV-infected Infant after Early ART [VIDEO]
- Details
- Category: Search for a Cure
- Published on Wednesday, 20 March 2013 00:00
- Written by Gregory Fowler
The big news on the opening day of the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) was a report about an infant with HIV who started combination antiretroviral treatment very early and now shows no evidence of replication-competent virus. "We equate this to our Berlin Patient," said Deborah Persaud from Johns Hopkins University School of Medicine. "It could get us on the road to a cure for HIV-infected children."
Web Design and Development by